To address the growing threat of coronavirus variants, the European Commission has launched four calls for research to complement earlier actions in the fight against SARS-CoV-2/COVID-19.
The Commission is mobilising €123 million to fund urgent research into coronavirus variants. This first emergency funding under Horizon Europe (the new EU research and innovation programme) contributes to the Commission’s actions to fight the pandemic and address the impact of variants in line with HERA Incubator, the new European bio-defence preparedness plan.
Projects that receive funding are expected to:
- establish multi-centre, regional or multinational cohorts, including beyond Europe's borders;
- further develop promising therapeutic or vaccine candidates against SARS-CoV-2/COVID-19;
- strengthen research infrastructures to accelerate data sharing and research support.
FAIR and open data sharing in support to European preparedness for COVID-19 and other infectious diseases
Research infrastructure services for rapid research responses to COVID-19 and other infectious disease epidemics
Vaccines & therapeutic clinical trials to boost COVID-19 prevention and treatment
Cohorts united against COVID-19 variants of concern